Evidence map›Paper›PMID 39005937›Full record

ArticleFrontiers in pharmacology2024

Adenosine A

Plinio Marcos Freire Dos Santos, Chyntia Carolina Díaz Acosta, Thabatta Leal Silveira Andrezo Rosa, Michelle Harumi Ishiba, André Alves Dias, Antonio Marcos Rodrigues Pereira, Luísa Domingos Gutierres, Melissa Pontes Pereira, Matheus da Silva Rocha, Patrícia Sammarco Rosa and 9 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. AMetabolites · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Plinio Marcos Freire Dos SantosLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Chyntia Carolina Díaz AcostaLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Thabatta Leal Silveira Andrezo RosaLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Michelle Harumi IshibaLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
André Alves DiasLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Antonio Marcos Rodrigues PereiraLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Luísa Domingos GutierresLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Melissa Pontes PereiraLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Matheus da Silva RochaLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Patrícia Sammarco RosaDivisão de Pesquisa e Ensino, Instituto Lauro de Souza Lima, São Paulo, Brazil.
Daniele F F BertoluciDivisão de Pesquisa e Ensino, Instituto Lauro de Souza Lima, São Paulo, Brazil.
José Roberto Meyer-FernandesLaboratório de Bioquímica Celular, Instituto de Bioquímica Médica Leopoldo de Meis, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Fabricio da Mota Ramalho CostaDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States.
Maria Angela M MarquesDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States.
John T BelisleDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States.
Roberta Olmo PinheiroLaboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Luciana Silva RodriguesLaboratório de Imunopatologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Maria Cristina Vidal PessolaniLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Marcia Berrêdo-PinhoLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Funding

The Role of Schwann Cell Lipid Droplets In Neuropathology of LeprosyR01AI141526 · NIAID · COLORADO STATE UNIVERSITY · PI BELISLE, JOHN T, PESSOLANI, MARIA CRISTINA VIDAL · 2019 to 2023
$3.1M
NIAID NIH HHS R01 AI141526
6 · The paper itself

Abstract

Background: Leprosy is a chronic infectious disease caused by Methods: Results: We demonstrated that Conclusion: These findings suggest the involvement of the AdoS in leprosy neuropathogenesis and support the idea that

Indexed as

A2A receptoradenosinergic systembacterial viabilityLeprosylipid dropletM. lepraeschwann cell

Identifiers

PMID39005937
PMCPMC11239521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.